Issue Date | Title | Author(s) |
2012 | Clinical pathway for surgical treatment of primary lung cancer (2012 Edition) | Zhi, Xiu-Yi; He, Jian-Xing; Li, Hui; Zhang, Xun; Jiang, Ge-Ning; Zhao, Heng; Liu, Lun-Xu; Liu, De-Ruo; Li, Shan-Qing; Li, Jian; Zhou, Qing-Hua; Wang, Qun; Wang, Ru-Wen; Fu, Jian-Hua; Xu, Lin; Zhang, Lin-You; Zhou, Nai-Kang; Xu, Shao-Fa |
2016 | Integrating differential pathway analysis with Monte Carlo cross-validation reveals seed cross-talks in non-small cell lung carcinoma | Zheng, Meng-Li; Zhou, Nai-Kang; Luo, Cheng-Hua |
2016 | MiRNA-155 and miRNA-132 as potential diagnostic biomarkers for pulmonary tuberculosis: A preliminary study | Zheng, Meng-Li; Zhou, Nai-Kang; Luo, Cheng-Hua |
2013 | A NON-INTERVENTIONAL STUDY ON EGFR MUTATION STATUS AND CLINICAL OUTCOMES OF CHINESE PATIENTS WITH COMPLETELY RESECTED LUNG ADENOCARCINOMA (ICAN STUDY) | Wu, Yi-Long; Wang, Jun; Chu, Xiang-Yang; Liu, Zhi-Dong; Shen, Yi; Ma, Haitao; Fu, Xiang-Ning; Hu, Jian; Zhou, Nai-Kang; Liu, Yongyu; Zhou, Xinming; Wang, Jian-Jun; Yang, Kang; Li, Jian; Xu, Lin; Wang, Si-Yu; Wang, Qun; Liu, Lun-Xu; Xu, Shun; Li, Shanqing; Chen, Zhongyuan; Luo, Honghe; Chen, Ying; Wang, Changli |
2017 | Pathway cross-talk network strategy reveals key pathways in non-small cell lung cancer | Zheng, Meng-Li; Zhou, Nai-Kang; Huang, De-Liang; Luo, Cheng-Hua |
2013 | A prospective comparison study on EGFR mutations by direct sequencing and ARMS in completely resected Chinese non-small cell lung cancer with adenocarcinoma histology (ICAN) | Zhang, Xuchao; Wu, Yi Long; Wang, Jun; Chu, Xiang-Yang; Liu, Zhi-Dong; Shen, Yi; Ma, Haitao; Fu, Xiang-Ning; Hu, Jian; Zhou, Nai-Kang; Liu, Yongyu; Zhou, Xinming; Wang, Jian-Jun; Yang, Kang; Xu, Lin; Li, Jian; Wang, Si-Yu; Wang, Qun; Liu, Lun-Xu; Xu, Shun |
2018 | Utilizing multiple pathway cross-talk networks reveals hub pathways in primary mediastinal B-cell lymphoma | Zheng, Meng-Li; Zhou, Nai-Kang; Luo, Cheng-Hua |